RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 822 - per page Next page
Order by
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Orally Bioavailable LHRH Antagonistic Peptidomimetics: Treatment of Endometriosis, Uterus Myoma, BPH and Malignant Disorders such as Breast and Prostate Cancer More
Superior Alternative to Pads and Tampons More
Cliovelle - a low dose Estradiol / Progestin combination product for treatment of menopausal disorders. More
Currently, LTS has two matrix formulation under development varying in their manufacturing process More
DNA-Based Therapeutic Angiogenesis / Protein Therapeutic for Thrombocytopenia / Therapeutic Cancer Vaccine Targeting HER2/neu / Hardy Kiwi Extract for Immune Hypersensitivity More
2,5mg and 5mg Zolmitriptan Rapidfilm® uses oral dissolving film strip technology without need of water. More
Compatible Permeation Enhancement Excipients: Enhancing Transmucosal and Transdermal Drug Delivery More
Transgenic mice for screening compounds with therapeutic potential against pain, hyper-thyroidism or obesity. These transgenic mice over-express DREAM, a transcriptional repressor More
Displaying 1..10 of 822 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us